Patent · US Active

Methods and compositions for treating luminal inflammatory disease

US7874975B2 · kind B2 · utility

1Cited by

23References

5Claims

0Family size

Assignee

Clear Vascular Inc. · US

Inventors

Gilbert R. Gonzales · New York, US
Nicolas Chronos · Atlanta, US

Key dates

Filing date	Jul 5, 2006
Grant date	Jan 25, 2011
Priority date	—
Expiry date	Jul 5, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, articles, and methods for treating and imaging vulnerable plaque and other inflamed regions in a patient rely on delivery of a conversion electron emitting source (CEES) to a body location. The CEES may be delivered by coupling to a substance which preferentially binds to vulnerable plaque or other inflammatory marker. Alternatively, the CEES can be delivered on a catheter, scaffold, or other device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.